H4CBD: why this cannabinoid is prohibited in France

H4CBD, or hydrogenated CBD, is a semi-synthetic cannabinoid obtained by hydrogenating natural CBD, a chemical process that alters its molecular structure. This transformation does not produce an "improved" CBD, as some sellers presented it, but a distinct molecule whose effects and safety are poorly documented.

Unlike CBD extracted directly from hemp, H4CBD does not occur naturally in the plant in any significant quantity. It is made in a laboratory, which puts it closer to a synthetic derivative than to a conventional plant extract.

The French national agency for medicines safety (ANSM) decided on 22 May 2024 to add H4CBD to the list of narcotics (source: ANSM). This decision forms part of a wider watch on the synthetic cannabinoids that have appeared on the market in recent years, whose effects and toxicity remain poorly assessed.

Classification as a narcotic places H4CBD in the same legal category as substances whose possession, production and sale are strictly controlled, and may carry criminal penalties.

The 2024 prohibition was not limited to H4CBD. It also covered H2CBD, THCP, THCA and HHCPO (source: ANSM). These molecules share common features: they are either semi-synthetic or the product of transformation processes that heighten their psychoactive potential compared with well-characterised natural cannabinoids.

THCA, for example, is a natural precursor of THC that converts on heating; its classification illustrates the precautionary logic adopted by the ANSM towards molecules capable of producing effects close to those of THC.

Since the ban, a product compliant with French regulation can no longer contain H4CBD. It is advisable to check the composition stated on the label and to favour natural CBD extracts whose THC content stays below the authorised threshold.

A product that explicitly advertises H4CBD, or that remains vague about its exact composition, should put the buyer on alert. Traceability and laboratory analysis remain the best guides for making sure a product complies with the legal framework, a useful point to know before adjusting your consumption habits (see our article on how much CBD per day according to the EFSA).

Is H4CBD still on sale in France?

No, its production, sale and use have been prohibited since 3 June 2024 (source: ANSM). A product that still contains it does not comply with the regulations.

Is H4CBD the same as ordinary CBD?

No, it is a semi-synthetic molecule obtained by hydrogenating CBD, distinct from the natural CBD extracted from hemp. Its chemical profile differs, which is what led to its classification as a narcotic.

Which other molecules were prohibited at the same time?

The ANSM decision of 22 May 2024 also covered H2CBD, THCP, THCA and HHCPO. All share a semi-synthetic status or a psychoactive potential judged problematic by the agency.

How can you tell whether a CBD product complies with the law?

Check the composition on the label and favour products accompanied by an independent laboratory analysis. A compliant product never lists H4CBD, THCA or the other molecules prohibited since June 2024.